{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:10:12Z","timestamp":1773058212562,"version":"3.50.1"},"reference-count":26,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20290"],"award-info":[{"award-number":["U22A20290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170180"],"award-info":[{"award-number":["82170180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800163"],"award-info":[{"award-number":["81800163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2020J011246"],"award-info":[{"award-number":["2020J011246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2020GGB054"],"award-info":[{"award-number":["2020GGB054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2021J011359"],"award-info":[{"award-number":["2021J011359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["CORP-117"],"award-info":[{"award-number":["CORP-117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["3502Z20209003"],"award-info":[{"award-number":["3502Z20209003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["3502Z20209008"],"award-info":[{"award-number":["3502Z20209008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["U22A20290"],"award-info":[{"award-number":["U22A20290"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["82170180"],"award-info":[{"award-number":["82170180"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["81800163"],"award-info":[{"award-number":["81800163"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["2020J011246"],"award-info":[{"award-number":["2020J011246"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["2020GGB054"],"award-info":[{"award-number":["2020GGB054"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["2021J011359"],"award-info":[{"award-number":["2021J011359"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["CORP-117"],"award-info":[{"award-number":["CORP-117"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["3502Z20209003"],"award-info":[{"award-number":["3502Z20209003"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["3502Z20209008"],"award-info":[{"award-number":["3502Z20209008"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["U22A20290"],"award-info":[{"award-number":["U22A20290"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["82170180"],"award-info":[{"award-number":["82170180"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["81800163"],"award-info":[{"award-number":["81800163"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["2020J011246"],"award-info":[{"award-number":["2020J011246"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["2020GGB054"],"award-info":[{"award-number":["2020GGB054"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["2021J011359"],"award-info":[{"award-number":["2021J011359"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["CORP-117"],"award-info":[{"award-number":["CORP-117"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["3502Z20209003"],"award-info":[{"award-number":["3502Z20209003"]}]},{"name":"Lymphoma Research Fund of the Chinese Anti-Cancer Association","award":["3502Z20209008"],"award-info":[{"award-number":["3502Z20209008"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["U22A20290"],"award-info":[{"award-number":["U22A20290"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["82170180"],"award-info":[{"award-number":["82170180"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["81800163"],"award-info":[{"award-number":["81800163"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["2020J011246"],"award-info":[{"award-number":["2020J011246"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["2020GGB054"],"award-info":[{"award-number":["2020GGB054"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["2021J011359"],"award-info":[{"award-number":["2021J011359"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["CORP-117"],"award-info":[{"award-number":["CORP-117"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["3502Z20209003"],"award-info":[{"award-number":["3502Z20209003"]}]},{"name":"Xiamen Municipal Bureau of Science and Technology","award":["3502Z20209008"],"award-info":[{"award-number":["3502Z20209008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Transformed follicular lymphoma (t-FL), for which there is no efficient treatment strategy, has a rapid progression, treatment resistance, and poor prognosis, which are the main reasons for FL treatment failure. In this study, we identified a promising therapeutic approach with chiauranib, a novel orally developed multitarget inhibitor targeting VEGFR\/Aurora B\/CSF-1R. We first determined the cytotoxicity of chiauranib in t-FL cell lines through CCK-8, EdU staining, flow cytometry, and transwell assays. We also determined the killing effect of chiauranib in a xenograft model. More importantly, we identified the underlying mechanism of chiauranib in t-FL tumorigenesis by immunofluorescence and Western blotting. Treatment with chiauranib significantly inhibited cell growth and migration, promoted apoptosis, induced cell cycle arrest in G2\/M phase, and resulted in significant killing in vivo. Mechanistically, chiauranib suppresses the phosphorylation level of VEGFR2, which has an anti-t-FL effect by inhibiting the downstream MEK\/ERK\/STAT3 signaling cascade. In conclusion, chiauranib may be a potential therapy to treat t-FL, since it inhibits tumor growth and migration and induces apoptosis by altering the VEGFR2\/ERK\/STAT3 signaling pathway.<\/jats:p>","DOI":"10.3390\/ph16010015","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T01:42:13Z","timestamp":1671759733000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2\/ERK\/STAT3 Signaling Pathway"],"prefix":"10.3390","volume":"16","author":[{"given":"Yuanfang","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"},{"name":"State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, Xiamen 361002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengya","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangchao","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinshui","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chendi","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"},{"name":"State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, Xiamen 361002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-1946","authenticated-orcid":false,"given":"Yuelong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihang","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"},{"name":"State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, Xiamen 361002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiewen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"},{"name":"School of Pharmaceutical Sciences, Xiamen University, Xiamen 361002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zha","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen 361003, China"},{"name":"Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","article-title":"Follicular lymphoma","volume":"5","author":"Carbone","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00277-017-3151-2","article-title":"Transformed follicular lymphoma","volume":"97","author":"Fischer","year":"2018","journal-title":"Ann. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/blood-2018-04-839217","article-title":"Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed\/refractory diffuse large B-cell lymphoma","volume":"132","author":"Chow","year":"2018","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","article-title":"Transformed follicular non-Hodgkin lymphoma","volume":"125","author":"Casulo","year":"2015","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/leu.2014.251","article-title":"Follicular lymphoma in Sweden: Nationwide improved survival in the rituximab era, particularly in elderly women: A Swedish Lymphoma Registry study","volume":"29","author":"Junlen","year":"2015","journal-title":"Leukemia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbmt.2017.12.771","article-title":"Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis","volume":"24","author":"Casulo","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/cas.13141","article-title":"CS2164, a novel multi-target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti-tumor potency","volume":"108","author":"Zhou","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.ejmech.2017.10.021","article-title":"Dual or multi-targeting inhibitors: The next generation anticancer agents","volume":"143","author":"Raghavendra","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/CAD.0000000000000791","article-title":"Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models","volume":"30","author":"Zhou","year":"2019","journal-title":"Anticancer Drugs"},{"key":"ref_10","first-page":"3666","article-title":"Chiauranib selectively inhibits colorectal cancer with KRAS wild-type by modulation of ROS through activating the p53 signaling pathway","volume":"10","author":"Yin","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yexcr.2018.05.038","article-title":"CS2164 exerts an antitumor effect against human Non-Hodgkin\u2019s lymphomas in vitro and in vivo","volume":"369","author":"Deng","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13045-018-0695-0","article-title":"Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors","volume":"12","author":"Sun","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2019.03.041","article-title":"CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models","volume":"853","author":"Deng","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ma, J., Hu, X., Liao, C., Xiao, H., Zhu, Q., Li, Y., Liu, Z., Tao, A., He, Z., and Xu, C. (2019). Gypenoside L Inhibits Proliferation of Liver and Esophageal Cancer Cells by Inducing Senescence. Molecules, 24.","DOI":"10.3390\/molecules24061054"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wu, P.K., Becker, A., and Park, J.I. (2020). Growth Inhibitory Signaling of the Raf\/MEK\/ERK Pathway. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155436"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","article-title":"STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/jnc.15531","article-title":"Zinc induces reactive astrogliosis through ERK-dependent activation of Stat3 and promotes synaptic degeneration","volume":"159","author":"Huiliang","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in Cancer Immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1074\/jbc.M706976200","article-title":"Identification of novel direct Stat3 target genes for control of growth and differentiation","volume":"283","author":"Snyder","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1593\/neo.121962","article-title":"The role of angiogenesis in human non-Hodgkin lymphomas","volume":"15","author":"Ribatti","year":"2013","journal-title":"Neoplasia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2012.07.126","article-title":"A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma","volume":"128","author":"Campos","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lian, L., Li, X.L., Xu, M.D., Li, X.M., Wu, M.Y., Zhang, Y., Tao, M., Li, W., Shen, X.M., and Zhou, C. (2019). VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5322-0"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/annonc\/mdn666","article-title":"Angiogenesis and antiangiogenic therapy in non-Hodgkin\u2019s lymphoma","volume":"20","author":"Ruan","year":"2009","journal-title":"Ann. Oncol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/1\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:48:14Z","timestamp":1760147294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/1\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ph16010015"],"URL":"https:\/\/doi.org\/10.3390\/ph16010015","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]}}}